‘I’m not trying to turn GSK into Google’: How GSK’s Silicon Valley veteran has transformed the pharma giant into a tech powerhouse
For GSK’s Ramakrishnan, who has served as CDTO since 2021, the biggest challenge was helping her company get a head start in ...
GSK studying if best-selling shingles vaccine lowers dementia risk
GSK said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its ...
GSK Wants UK to Open Up Health Records to Boost Drug Development
GSK Plc is pushing the UK government to give pharmaceutical companies more access to its public health data troves, to ...
GSK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of GSK plc to Contact the Firm Today!
NEW YORK CITY, NY / ACCESS Newswire / March 28, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...
Fierce Pharma6d
GSK ushers in new UTI antibiotic with FDA nod for first-in-class Blujepa
GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...
U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine
The inquiry is looking into a politically explosive suggestion that Pfizer delayed announcing a successful vaccine against ...
Explore more
Barclays Keeps Their Hold Rating on GlaxoSmithKline (GSK)
Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...
US FDA greenlights GSK's drug for UTIs in women and girls
The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in ...
GSK Studying If Blockbuster Shingles Shot Reduces Dementia Risk
GSK Plc is studying a large group of elderly adults in the UK to determine if its blockbuster shingles vaccine reduces the risk of dementia, potentially opening the door to an expanded label for the ...
US FDA approves GSK's urinary tract infection drug
The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in ...
GSK falls Monday, underperforms market
GSK PLC closed 18.56% short of its 52-week high of £18.24, which the company achieved on May 16th.
FDA greenlights GSK’s drug for UTIs in women and girls
The FDA approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new ...